| Kathryn T Turner, CRNA | |
|
110 Irving St Nw, Washington, DC 20010-2976 | |
| (301) 946-5100 | |
| (301) 929-0348 |
| Full Name | Kathryn T Turner |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 110 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013022649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN36546 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn T Turner, CRNA 11510 Georgia Ave, Suite 206, Wheaton, MD 20902-1925 Ph: (301) 946-5100 | Kathryn T Turner, CRNA 110 Irving St Nw, Washington, DC 20010-2976 Ph: (301) 946-5100 |
News Archive
Men being treated for prostate cancer using hormone therapy maybe under-recognized for their risk of developing osteoporosis, according to a new study.
A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Sprycel (dasatinib) for the treatment of adults in all phases of chronic myeloid leukemia (CML) (chronic, accelerated, or myeloid or lymphoid blast phase) with resistance or intolerance to prior therapy including Gleevec (imatinib mesylate).
Researchers have shown that the communication signals sent around the body by cancer cells, which are essential for the cancer to grow, may contain pieces of RNA - these substances, like DNA, are pieces of genetic code that can instruct cells, and ultimately the body, how to form. The same study also found early indications that these genetic instructions can be intercepted and modified by chemotherapy to help prevent cancer cells growing.
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
› Verified 5 days ago
Miss Ore-oluwa Odulana Lima Da Silva, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7504 | |
Glenise Lynn Sanchez Perez, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Barbara Pursell, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-4904 | |
Vera Tantoco, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8640 | |
Donna Jasinski, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8640 | |
Ms. Jane Ann Skelton, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 110 Irving St Nw, Dept. Anesthesia Angie Edwards, Washington, DC 20016 Phone: 202-877-7000 |